Patents by Inventor John T. Smolik

John T. Smolik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High energy phototherapeutic agents
    Patent number: 7384623
    Abstract: High energy phototherapeutic agents or radiosensitizer agents comprised of a halogenated xanthene, or other related agents that exhibit a preference for concentration in biologically sensitive structures in diseased tissue, and methods of treating and imaging using such radiosensitizer agents in such diseased tissue are described herein.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: June 10, 2008
    Assignee: Provectus Pharmatech, Inc.
    Inventors: H. Craig Dees, Timothy Scott, John T. Smolik, Eric A. Wachter
  • Methods and apparatus for multi-photon photo-activation of therapeutic agents
    Patent number: 7353829
    Abstract: A method and apparatus for the treatment of a particular volume of material, plant or animal tissue including the steps of treating the material plant or animal tissue with at least one photo-active agent, wherein the particular volume of the material, plant or animal tissue retains at least a portion of the at least one photo-active agent, and then treating the particular volume of the material plant or animal tissue with light sufficient to promote a multi-photon excitation of at least one of the at least one photo-active agent retained in the particular volume of the material, plant or animal tissue, wherein the at least one photo-active agent becomes active in the particular volume of the material, plant or animal tissue.
    Type: Grant
    Filed: June 12, 1998
    Date of Patent: April 8, 2008
    Assignee: Provectus Devicetech, Inc.
    Inventors: Eric A. Wachter, Walter G. Fisher, John T. Smolik
  • Methods for high energy phototherapeutics
    Patent number: 6331286
    Abstract: Methods of treating and imaging diseased tissue having the steps of administering a radiosensitizer agent proximate to or into the diseased tissue; and treating the diseased tissue with x-rays or other ionizing radiation so as to activate the radiosensitizer agent in the diseased tissue. Preferably, the radiosensitizer agent is a halogenated xanthene.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: December 18, 2001
    Assignee: Photogen, Inc.
    Inventors: H. Craig Dees, Timothy Scott, John T. Smolik, Eric A. Wachter